Cellebrite DI Ltd.

Cellebrite DI Ltd.

CLBT

$11.39

Updated: 24/09/2026, 16:06:16

Market Cap
$2.85B
Sector
Technology
Industry
Software - Infrastructure
Country
IL
Stock valuation chart
One-year closing share-price history for CLBT
Company Profile

Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, scrutinize, interpret, and oversee digital information throughout the investigative process. These essential tools are utilized in a wide array of scenarios, including cases involving child exploitation, homicides, counter-terrorism operations, border control, sexual offenses, human trafficking, corporate security incidents, intellectual property theft, and civil litigation. A key offering, the Universal Forensic Extraction Device (UFED), is engineered to surmount significant hurdles in accessing digital evidence, such as intricate device locks, encryption barriers, deleted data, and obscure content that might otherwise conceal crucial information. The company also provides Seeker, designed for analyzing video footage; OSINT Analyze, a real-time deep-dive tool for examining open-source information across the surface, deep, and dark web; and Crypto Tracer, which deciphers blockchain transactions alongside related data from numerous sources to identify and categorize digital wallets and activities. Cellebrite's clientele includes federal, state, and local government bodies, as well as various enterprise companies and service providers. Established in 1999 and headquartered in Petah Tikva, Israel, the firm operates internationally with a footprint in countries such as the United States, Germany, Singapore, Australia, Brazil, the United Kingdom, France, Canada, Japan, and India. Additionally, Cellebrite Mobile Synchronization Ltd. functions as a subsidiary of Sun Corporation.

USD
NASDAQ
CEO: Shiv Ramji
Employees: 1,285
https://www.cellebrite.com
Asset Summaries
Latest generated summaries for CLBT

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for CLBT.
Share price
$11.39
Market cap
$2.85B
Exchange
NASDAQ
Currency
USD
CEO
Shiv Ramji
Employees
1,285
IPO date
06/11/2020
Beta
1.146
Last dividend
$0.00
Day range
$11.36 – $11.55
52-week range
$9.58 – $19.98
1-day performance
-0.96%
1-year performance
18.89%
Current drawdown (1Y)
-42.99%
CIK
0001854587
CUSIP
M2197Q107
ISIN
IL0011794802
Created
07/12/2025, 03:20:25
Last update
24/09/2026, 16:06:16

Track Cellebrite DI Ltd. with an AI analyst

See which prediction-market events move CLBT, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to CLBT from your Railway `news_articles` table.

Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript

Seeking Alpha • STOCK • 10/06/2026, 15:02:15

Cellebrite Launches the New Age of Investigations with Genesis, Now Generally Available

PRNewsWire • STOCK • 10/06/2026, 10:30:00

Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows

MarketBeat • STOCK • 28/05/2026, 05:04:27

Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth

MarketBeat • STOCK • 19/05/2026, 01:04:37

Cellebrite DI Ltd. (CLBT) Presents at J.P.

Seeking Alpha • STOCK • 18/05/2026, 19:10:46

Cellebrite: Positive Q1 Results, But There Is Room For Margin Improvements

Seeking Alpha • STOCK • 16/05/2026, 10:45:09

Cellebrite DI Ltd. (NASDAQ:CLBT) Shows Strong Q1 Growth Despite Analyst Price Target Adjustment

Market Data • Market Data • 15/05/2026, 17:19:36

Cellebrite DI Q1 Earnings Call Highlights

MarketBeat • STOCK • 14/05/2026, 12:09:32

Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Top Estimates

Zacks Investment Research • STOCK • 14/05/2026, 11:21:15

Cellebrite: A Rare SaaS Play Where AI Is A Tailwind, Not A Threat

Seeking Alpha • STOCK • 06/04/2026, 17:19:34

Cellebrite Changes the Investigative Game with the Launch of Genesis, the Groundbreaking Agentic AI Solution for Making Our World Safer

PRNewsWire • STOCK • 16/03/2026, 09:30:00

Cellebrite DI Ltd. (CLBT) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

Seeking Alpha • STOCK • 03/03/2026, 14:02:14